Press Release | 07/27/2021
FOR IMMEDIATE RELEASE:/6:00 AM Niksic, Montenegro / July 27, 2021/ Institute of Biomedical Research, Corp. (OTC PINK: MRES) $MRES. The Company Updates Shareholders and Potential Investors of Management’s Approval of its Application to OTCIQ. The Company will begin uploading to OTC Markets all required and fillings and updates to achieve Pink Current Status.
“The Company will adhere to OTC Markets and SEC guidelines for Best Practices for Disclosure and Transparency” stated Kim Halvorson, Institute for Biomedical Research, Corp.’s CEO and Director.
In adhering to these guidelines, the Company is in good standing with the state of Nevada, and federal taxation departments. The Company is in good standing with the Transfer Agent. All Share information will be automatically updated on OTC Markets.
OTC Markets has approved MRES to access and update the profile page and begin the process of MRES to upload financials. As of today, the Company will begin to upload the previous two calendar years 2019 and 2020 with the OTC Markets Annual and Quarterly Disclosure Statements for the respective financial periods.
The Company believes it needs to be in good standing for it to provide shareholder value. The more transparent that it is with financials and its business plan, the better confidence it brings for the investors. The Company aims to build trust and long-term investors by also engaging a new SEC Attorney, CPA and Auditor to help guide our transition to Pink Current Status.
“The business plan permits growth in shareholder value and the Company is not stopping at Pink Current. We are excited about getting OTCIQ access. The Company has not had this in many years, we are emancipating from this status so that we can provide new vigor to the Company” commented Kim Halvorson, CEO.
Please note: The company does not currently have any social media accounts. All updates and progress will be updated on the OTCIQ profile and through proper disclosure outlets to the public. Please do not contact the company for any information that is not readily available to the public. Any social media sites and or information can not be relied upon.
ABOUT: INSTITUTE OF BIOMEDICAL RESEARCH CORPORATION
The Institute of Biomedical Research is a biomedically ambitious business venture whose activities extend from highly diversified scientific research and sophisticated services combining the latest science and naturally occurring compounds and extracts. The Company looks to expand its major long term biomedical and environmental research projects, as well as the development of new diagnostic technologies and innovative experimental medical treatments. The research of new therapies and biomedical products also constitutes important business activities of the Institute. The Institute is essential for the development of Montenegro within the regional and European environment. This is now with new offices in the Biotech Research Center of the Pacific Northwest, South Lake Union, Seattle Washington.
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Signed.
/S/ Ms. K Halvorson, CEO
FOR MORE INFORMATION, PLEASE CONTACT:
For more information, press only:
CONTACT: Kim Halvorson
info@mrescorp.com
Website: www.mrescorp.com